ACADIA Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript
So good morning, everyone, and thanks for attending Day 3 of Citi's 16th Annual Biopharma Conference. I am Neena Bitritto-Garg, one of the biotech analysts here at Citi. And I am really pleased to be joined for our next fireside chat by the management team from ACADIA Pharmaceuticals, including CEO, Steve Davis; President Serge Stankovic; and the Interim CFO, Mark Schneyer.
And before we get into the discussion, I do want to note that if you have any questions, feel free to either e-mail me directly or submit questions through the online portal, and I will answer them or I will address them as time permits. So now I just wanted to turn it over to Steve to make some opening remarks.
Great. Thanks so much, Neena. I'd like to start just by doing a little bit of level setting. I'll try to make it brief, so that we can get on to the Q&A. And then I'll ask Mark to introduce himself.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
